UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 53

Sortiert nach

Nonmyeloablative conditioning, unmanipulated haploidentical SCT and post-infusion CY for advanced lymphomas

Bone marrow transplantation (Basingstoke), 2014-12, Vol.49 (12), p.1475-1480

2014

Volltextzugriff (PDF)

Impact of in vivo T-cell depletion on outcome of AML patients in first CR given peripheral blood stem cells and reduced-intensity conditioning allo-SCT from a HLA-identical sibling donor: a report from the Acute Leukemia Working Party of the European group for Blood and Marrow Transplantation

Bone marrow transplantation (Basingstoke), 2014-03, Vol.49 (3), p.389-396

2014

Volltextzugriff (PDF)

The increase from 2.5 to 5 mg/kg of rabbit anti-thymocyte-globulin dose in reduced intensity conditioning reduces acute and chronic GVHD for patients with myeloid malignancies undergoing allo-SCT

Bone marrow transplantation (Basingstoke), 2012-05, Vol.47 (5), p.639-645

2012

Volltextzugriff (PDF)

Matched unrelated donor allogeneic transplantation provides comparable long-term outcome to HLA-identical sibling transplantation in relapsed diffuse large B-cell lymphoma

Bone marrow transplantation (Basingstoke), 2014-05, Vol.49 (5), p.671-678

2014

Volltextzugriff (PDF)

Allo-SCT for Philadelphia-negative myeloproliferative neoplasms in blast phase: a study from the Societe Française de Greffe de Moelle et de Therapie Cellulaire (SFGM-TC)

Bone marrow transplantation (Basingstoke), 2014-06, Vol.49 (6), p.756-760

2014

Volltextzugriff (PDF)

An EBMT registry matched study of allogeneic stem cell transplants for lymphoma: allogeneic transplantation is associated with a lower relapse rate but a higher procedure-related mortality rate than autologous transplantation

Bone marrow transplantation (Basingstoke), 2003-04, Vol.31 (8), p.667-678

2003

Volltextzugriff (PDF)

Lenalidomide as salvage therapy after allo-SCT for multiple myeloma is effective and leads to an increase of activated NK (NKp44 ) and T (HLA-DR ) cells

Bone marrow transplantation (Basingstoke), 2010-02, Vol.45 (2), p.349-353

2010

Volltextzugriff (PDF)

Efficacy and safety of micafungin for prophylaxis of invasive fungal infections in patients undergoing haplo-identical hematopoietic SCT

Bone marrow transplantation (Basingstoke), 2013-11, Vol.48 (11), p.1472-1477

2013

Volltextzugriff (PDF)

Reduced-intensity conditioning regimen with in vivo T-cell depletion for patients with haematological malignancies: results using unrelated and sibling donors

Bone marrow transplantation (Basingstoke), 2014-09, Vol.49 (9), p.1246-1247

2014

Volltextzugriff (PDF)

Use of G-CSF to hasten neutrophil recovery after auto-SCT for AML is not associated with increased relapse incidence: a report from the Acute Leukemia Working Party of the EBMT

Bone marrow transplantation (Basingstoke), 2014-07, Vol.49 (7), p.950-954

2014

Volltextzugriff (PDF)

Tandem autologous-allo-SCT is feasible in patients with high-risk relapsed non-Hodgkin's lymphoma

Bone marrow transplantation (Basingstoke), 2013-02, Vol.48 (2), p.249-252

2013

Volltextzugriff (PDF)

Outcomes of adults with active or progressive hematological malignancies at the time of allo-SCT: a survey from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)

Bone marrow transplantation (Basingstoke), 2014-03, Vol.49 (3), p.361-365

2014

Volltextzugriff (PDF)

Reduced-intensity conditioning allogeneic SCT as salvage treatment for relapsed multiple myeloma

Bone marrow transplantation (Basingstoke), 2008-06, Vol.41 (11), p.953-960

2008

Volltextzugriff (PDF)

Retrospective analysis of common scoring systems and outcome in patients older than 60 years treated with reduced-intensity conditioning regimen and alloSCT

Bone marrow transplantation (Basingstoke), 2011-07, Vol.46 (7), p.1000-1005

2011

Volltextzugriff (PDF)

Disease status is a more reliable predictive factor than histology in lymphoma patients after reduced-intensity conditioning regimen and allo-SCT

Bone marrow transplantation (Basingstoke), 2013-06, Vol.48 (6), p.794-798

2013

Volltextzugriff (PDF)

The impact of center experience on results of reduced intensity: allogeneic hematopoietic SCT for AML. An analysis from the Acute Leukemia Working Party of the EBMT

Bone marrow transplantation (Basingstoke), 2013-02, Vol.48 (2), p.238-242

2013

Volltextzugriff (PDF)

Allogeneic hematopoietic SCT for patients with autoimmune diseases

Bone marrow transplantation (Basingstoke), 2009-07, Vol.44 (1), p.27-33

2009

Volltextzugriff (PDF)

High rate of secondary viral and bacterial infections in patients undergoing allogeneic bone marrow mini-transplantation

Bone marrow transplantation (Basingstoke), 2000-08, Vol.26 (3), p.251-255

2000

Volltextzugriff (PDF)

TLI in refractory chronic GVHD

Bone marrow transplantation (Basingstoke), 2013-06, Vol.48 (6), p.854-858

2013

Volltextzugriff (PDF)

Graft-versus-myeloma effect following antithymocyte globulin-based reduced intensity conditioning allogeneic stem cell transplantation

Bone marrow transplantation (Basingstoke), 2004-07, Vol.34 (1), p.77-84

2004

Volltextzugriff (PDF)

The EBMT activity survey 2006 on hematopoietic stem cell transplantation: focus on the use of cord blood products

Bone marrow transplantation (Basingstoke), 2008-04, Vol.41 (8), p.687-705

2008

Volltextzugriff (PDF)

High-dose weekly liposomal amphotericin B antifungal prophylaxis following reduced-intensity conditioning allogeneic stem cell transplantation

Bone marrow transplantation (Basingstoke), 2007-03, Vol.39 (5), p.301-306

2007

Volltextzugriff (PDF)

Allogeneic hematopoietic cell transplantation for metastatic breast cancer

Bone marrow transplantation (Basingstoke), 2008-03, Vol.41 (6), p.537-545

2008

Volltextzugriff (PDF)

Allogeneic hematopoietic stem cell transplantation in ovarian carcinoma: results of five patients

Bone marrow transplantation (Basingstoke), 2002-07, Vol.30 (2), p.95-102

2002

Volltextzugriff (PDF)

Mycophenolate mofetil and cyclosporine for graft-versus-host disease prophylaxis following reduced intensity conditioning allogeneic stem cell transplantation

Bone marrow transplantation (Basingstoke), 2004-09, Vol.34 (6), p.527-530

2004

Volltextzugriff (PDF)

1 – 25 von 53

Suche als RSS-Feed

Aktive Filter

KollektionWiley Online Library All Journals

Zeitschrift / SerieArchives De Philosophie

Zeitschrift / SerieBone Marrow Transplantation

ThemaTransfusions. Complications. Transfusion Reactions. Cell And Gene Therapy

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(53)
Mit Volltextzugriff
(53)

Publikationsform

Artikel
(53)

Sprache

Englisch
(53)
Japanisch
(8)

Erscheinungsjahr

n.n

Thema

Anesthesia. Intensive Care Medicine. Transfusions. Cell Therapy And Gene Therapy
(53)
Biological And Medical Sciences
(53)
Bone Marrow, Stem Cells Transplantation. Graft Versus Host Reaction
(53)
Medical Sciences
(53)
Humans
(50)
Transplantation
(50)
Biophysics
(49)
Hematology
(49)
Immunology
(49)
Life Sciences & Biomedicine
(49)
Oncology
(49)
Science & Technology
(49)
Stem Cell Transplantation
(45)
Adult
(42)
Middle Aged
(39)
Bone Marrow
(38)
Female
(36)
Male
(34)
Stem Cells
(28)

14 weitere anzeigen...

Weniger anzeigen...

Kollektion

Nexis Uni
(53)
EZB Electronic Journals Library
(53)
Ovid SocietyJournals and Single Titles
(53)
Springer Nature - Connect here FIRST to enable access
(53)
MEDLINE
(50)
Ingenta
(18)
Wiley Online Library - AutoHoldings Journals
(0)

2 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Bone Marrow Transplant
(1)

Menü

Weitere Dienste

Einstellungen

Nonmyeloablative conditioning, unmanipulated haploidentical SCT and post-infusion CY for advanced lymphomas

Impact of in vivo T-cell depletion on outcome of AML patients in first CR given peripheral blood stem cells and reduced-intensity conditioning allo-SCT from a HLA-identical sibling donor: a report from the Acute Leukemia Working Party of the European group for Blood and Marrow Transplantation

The increase from 2.5 to 5 mg/kg of rabbit anti-thymocyte-globulin dose in reduced intensity conditioning reduces acute and chronic GVHD for patients with myeloid malignancies undergoing allo-SCT

Matched unrelated donor allogeneic transplantation provides comparable long-term outcome to HLA-identical sibling transplantation in relapsed diffuse large B-cell lymphoma

Allo-SCT for Philadelphia-negative myeloproliferative neoplasms in blast phase: a study from the Societe Française de Greffe de Moelle et de Therapie Cellulaire (SFGM-TC)

An EBMT registry matched study of allogeneic stem cell transplants for lymphoma: allogeneic transplantation is associated with a lower relapse rate but a higher procedure-related mortality rate than autologous transplantation

Lenalidomide as salvage therapy after allo-SCT for multiple myeloma is effective and leads to an increase of activated NK (NKp44 ) and T (HLA-DR ) cells

Efficacy and safety of micafungin for prophylaxis of invasive fungal infections in patients undergoing haplo-identical hematopoietic SCT

Reduced-intensity conditioning regimen with in vivo T-cell depletion for patients with haematological malignancies: results using unrelated and sibling donors

Use of G-CSF to hasten neutrophil recovery after auto-SCT for AML is not associated with increased relapse incidence: a report from the Acute Leukemia Working Party of the EBMT

Tandem autologous-allo-SCT is feasible in patients with high-risk relapsed non-Hodgkin's lymphoma

Outcomes of adults with active or progressive hematological malignancies at the time of allo-SCT: a survey from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)

Reduced-intensity conditioning allogeneic SCT as salvage treatment for relapsed multiple myeloma

Retrospective analysis of common scoring systems and outcome in patients older than 60 years treated with reduced-intensity conditioning regimen and alloSCT

Disease status is a more reliable predictive factor than histology in lymphoma patients after reduced-intensity conditioning regimen and allo-SCT

The impact of center experience on results of reduced intensity: allogeneic hematopoietic SCT for AML. An analysis from the Acute Leukemia Working Party of the EBMT

Allogeneic hematopoietic SCT for patients with autoimmune diseases

High rate of secondary viral and bacterial infections in patients undergoing allogeneic bone marrow mini-transplantation

TLI in refractory chronic GVHD

Graft-versus-myeloma effect following antithymocyte globulin-based reduced intensity conditioning allogeneic stem cell transplantation

The EBMT activity survey 2006 on hematopoietic stem cell transplantation: focus on the use of cord blood products

High-dose weekly liposomal amphotericin B antifungal prophylaxis following reduced-intensity conditioning allogeneic stem cell transplantation

Allogeneic hematopoietic cell transplantation for metastatic breast cancer

Allogeneic hematopoietic stem cell transplantation in ovarian carcinoma: results of five patients

Mycophenolate mofetil and cyclosporine for graft-versus-host disease prophylaxis following reduced intensity conditioning allogeneic stem cell transplantation

Aktive Filter

Suchergebnisse filtern